Small cell conversion complicated with hypertrophic pulmonary osteoarthropathy after targeted therapy for advanced EGFR-mutated lung adenocarcinoma: A case report

In recent years, with the opening of the era of precision therapy, the treatment of patients with positive driver genes is a hot issue in global research. EGFR is the most common driver gene in NSCLC, with a positivity rate of 17%. Although targeted drugs for EGFR mutations can benefit this populati...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Sijia Zhang, Leichong Chen, Kuikui Zhu, Rui Meng
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wolters Kluwer Medknow Publications 2023-03-01
Schriftenreihe:	Indian Journal of Pathology and Microbiology
Schlagworte:	case report egfr mutation hypertrophic pulmonary osteoarthropathy (hpoa) small cell conversion targeted therapy resistance
Online-Zugang:	https://journals.lww.com/10.4103/ijpm.ijpm_280_22
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!